α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies

Background: The objective of this study was to investigate the discriminating value of a range of CSF α‐synuclein species for dementia with Lewy bodies compared with Alzheimer's disease, PD, and cognitively normal controls. Methods: We applied our recently published enzyme‐linked immunosorbent...

Descripción completa

Detalles Bibliográficos
Autores principales: van Steenoven, Inger, Majbour, Nour K., Vaikath, Nishant N., Berendse, Henk W., van der Flier, Wiesje M., van de Berg, Wilma D.J., Teunissen, Charlotte E., Lemstra, Afina W., El‐Agnaf, Omar M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519232/
https://www.ncbi.nlm.nih.gov/pubmed/30440090
http://dx.doi.org/10.1002/mds.111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519232/
https://www.ncbi.nlm.nih.gov/pubmed/30440090
http://dx.doi.org/10.1002/mds.111

Ejemplares similares